bioRxivBioinformaticsPreprint
Circulating miR-4532 is associated with loss of ambulation in dysferlinopathy
Tajveer Singh GrewaliD, Zsuzsanna HollanderiD, Darlene L. Y. DaiiD, Virginia CheniD, Hillarie Plessner Windish, Douglas E. Albrecht, Elaine Lee Paoliello, Laura RufibachiD, Bradley Williams, Plavi MittaliD, Sara Assadian, Janet E Wilson-McManus, Bruce M. McManusiD, Raymond T. NgiD, Scott J. TebbuttiD, Pascal N. BernatcheziD, Amrit SinghiD
Abstract
BackgroundLimb-girdle muscular dystrophies (LGMDs) are inherited myopathies characterized mainly by progressive weakness of the proximal muscles of the shoulder and pelvic girdle areas, leading to functional decline and eventual loss of independent ambulation. Dysferlinopathy (LGMD2B) is an autosomal recessive LGMD subtype, is caused by mutations in the DYSF gene that lead to lack of dysferlin which results in muscle death and chronic muscle fiber degeneration. Preservation of ambulation is a key clinical milestone, as loss of independent gait markedly reduces quality of life and complicates care management. Although patients often perceive functional decline before their initial clinical presentation, current clinical assessments typically detect disease progression after substantial muscle damage has occurred. MethodsIn this multigroup case-control study, we profiled plasma miRNAs from 49 genetically confirmed dysferlinopathy patients (24 ambulatory, 25 non-ambulatory) and 25 age- and sex-matched healthy controls. Total RNA was extracted from blood samples and hybridized to Affymetrix GeneChip miRNA 3.1 arrays. After quality control and filtering, differential expression analysis was performed using linear models for microarrays, adjusting for age and sex, with a false discovery rate cutoff of 10%. Results14 miRNAs were significantly altered between dysferlinopathy patients and controls. Notably, miR-4532 was upregulated in ambulatory patients relative to controls, whereas it was downregulated in non-ambulatory patients compared with ambulatory patients, although expression levels remained higher than in controls. Levels of miR-4532 were positively associated with circulating monocyte levels in ambulatory patients only. ConclusionThese results suggest that miR-4532 may be a circulating marker associated with ambulatory status in dysferlinopathy. Its known involvement in inflammatory signaling and muscle regeneration pathways underscores its potential as an early indicator for disease activity.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DAB2 as a biomarker and mechanistic link between lipid dysregulation and disease progression in LGMD R2
Céline Bruge, Nathalie Bourg, … Xavier Nissan·bioRxiv·Sep 11, 2025
- Muscle transcriptome profiling reveals novel molecular pathways and biomarkers in laminin-α2 deficient patients
Veronica Pini, Francesco Catapano, … Francesco Muntoni A·Acta Neuropathologica CommunicationsPeer-reviewed·Feb 3, 2026
- A genome-wide association analysis of loss of ambulation in dystrophinopathy patients suggests multiple candidate modifiers of disease severity
Kevin M. Flanigan, Megan A. Waldrop, … Veronica J. Vieland·European Journal of Human GeneticsPeer-reviewed·Mar 20, 2023
- Pathogenic Mutations in the C2A Domain of Dysferlin form Amyloid that Activates the Inflammasome.
I. L. Scott, M. J. Dominguez, … R. B. Sutton·bioRxiv·Apr 24, 2023
- Early pathological signs in young dysf-/- mice are improved by halofuginone
H. Barzilai-Tutsch, O. Genin, … O. Halevy·bioRxiv·Sep 9, 2019
- miR-486 is an epigenetic modulator of Duchenne muscular dystrophy pathologies
Rylie M. Hightower, Adrienne Samani, … Matthew S. Alexander·bioRxiv·Jun 14, 2021